Imagion Biosystems hits key development milestone with initiation of toxicology study
Imagion Biosystems has achieved a key milestone in its progress to first-in-human testing with the commencement of a toxicology safety study of its lead…
Imagion Biosystems teams with Planet Innovation for MagSense® Instrument Development
Click to view press release on PR/Newswire MELBOURNE, Australia, Dec. 17, 2018 /PRNewswire/ -- Imagion Biosystems Limited (ASX: IBX), a company dedicated to…
MagSense® Pre-Clinical Safety Data from AACR 2018
Pre-clinical data on Imagion Biosystems' MagSense HER2+ cancer detection platform have shown: specific binding and detection of HER2+ tumor cells in vitro…